The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Open accessAbstract
Tumor-infiltrating T cells often lose their effector function; however, the mechanisms are incompletely understood. We report that cholesterol in the tumor microenvironment induces CD8+ T cell expression of immune checkpoints and exhaustion. Tumor tissues enriched with cholesterol and cholesterol content in tumor-infiltrating CD8+ T cells were positively and progressively associated with upregulated T cell expression of PD-1, 2B4, TIM-3, and LAG-3. Adoptively transferred CD8+ T cells acquired cholesterol, expressed high levels of immune checkpoints, and became exhausted upon entering a tumor. Tumor culture supernatant or cholesterol induced immune checkpoint expression by increasing endoplasmic reticulum (ER) stress in CD8+ T cells. Consequently, the ER stress sensor XBP1 was activated and regulated PD-1 and 2B4 transcription. Inhibiting XBP1 or reducing cholesterol in CD8+ T cells effectively restored antitumor activity. This study reveals a mechanism underlying T cell exhaustion and suggests a new strategy for restoring T cell function by reducing cholesterol to enhance T cell-based immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though both oxidative and ER stress have been shown to contribute to T cell dysfunction across different tumor types (44-51),”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 13×
“Tumor-infiltrating CD8+ T cells are associated with progressive loss of effector function due to prolonged antigen exposure and a suppressive tumor microenvironment (Wherry, 2011).”
InfluentialCTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · cited 1×
“, the combination of anti-PD-1 with anti-CTLA-4 (Buchbinder and Desai, 2016; Duraiswamy et al., 2013; Dyck and Mills, 2017), anti-PD-1 with anti-TIM-3 (Sakuishi et al.”
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Boussiotis, V. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1514296 · Cited by 1,372
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,304
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,000
AiErken, N., Shao, N., Liu, Y., Shi, H., Shi, Y., Yuan, Z., & Lin, Y. (2023) · Breast Care · doi:10.1159/000531943 · Cited by 2
Mangelinck, A., Molitor, E., Marchiq, I., Alaoui, L., Bouaziz, M., Andrade-Pereira, R., Darville, H., Becht, É., & Lefèbvre, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315980 · Cited by 2
Yamamoto, A., Shoda, K., Kawaguchi, Y., Akaike, H., Furuya, S., SHIRAISHI, K., Hirayama, K., Saito, R., ASHIZAWA, N., Takiguchi, K., et al. (2023) · Anticancer Research · doi:10.21873/anticanres.16233 · Cited by 2
Babl, N., Hofbauer, J., Matos, C., Voll, F., Menevse, A. N., Rechenmacher, M., Mair, R., Beckhove, P., Herr, W., Siska, P. J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1107484 · Cited by 2
Human ApoE2 protects mice against Plasmodium berghei ANKA experimental cerebral malaria
Liang, R., Rao, H., Pang, Q., Xu, R., Jiao, Z., Lin, L.-R., Li, L., Zhong, L., Zhang, Y., Guo, Y., et al. (2023) · mBio · doi:10.1128/mbio.02346-23 · Cited by 2
Cholesterol metabolism in prostate cancer
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00007-2 · Cited by 2
Lipotoxicity as a Barrier for T Cell-Based Therapies
Loschinski, R., Saborido, J. R., Böttcher, M., Kahlfuß, S., & Mougiakakos, D. (2022) · Biomolecules · doi:10.3390/biom12091182 · Cited by 2
Metabolic reprogramming and immunity in cancer
Chen, Y., & Li, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00006-5 · Cited by 2
Rapid assessment of paint coatings by micro and nano indentation methods
Wai, S. W. (2013) · Research Online (University of Wollongong) · Cited by 2
Disrupting cholesterol homeostasis in T cells boosts antitumour responses
Kennewick, K. T., & Bensinger, S. J. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01240-x · Cited by 2
Wang, X. F., Plebanek, M. P., Nguyen, Y., Bazaz, M. R., Sturdivant, M. S., Theivanthiran, B., & Hanks, B. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705213 · Cited by 2
Jiang, D., Wu, X., Chen, C., Ju, T., Du, Y., Yang, M., Cao, K., Chen, M., Zhou, W., Qi, J., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167646 · Cited by 1
Self-citationXiao, Y., Cao, C., Zhang, Y., Zhao, C., & Liu, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167962 · Cited by 1
Ma, L., Zhu, W., Wang, Y., Zhao, L., Wei, X., Xiong, X., & Ji, G. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1616302 · Cited by 1
Yetişyiğit, T., Karaboyun, K., İriağaç, Y., Çavdar, E., Öznur, M., Seber, S., & Turgut, B. (2025) · Medicine · doi:10.1097/md.0000000000044743 · Cited by 1
Cholesterol modulation in drug delivery systems and tumor therapy: Strategies and perspectives
Kang, S., Li, Y., Gao, Y., Kong, L., & Zhang, Z. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114317 · Cited by 1
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
Xu, L., Zhang, X., Lai, X., Chen, H., Liao, S., Chang, M., Wu, X., Rui, W., Yang, J., Wang, D., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0242 · Cited by 1
Statin repurposing in gastrointestinal cancer: from metabolic reprogramming to immunoregulation
Xu, M., Yu, C. M., Chung, H. K. H., & Zhou, J. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf187 · Cited by 1
Zhu, D., Guo, Y., Liu, W., Gong, B., Li, Y., Jiang, S., Li, Y., Miao, L., Li, L., & Yang, L. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101118 · Cited by 1
Zheng, R., Zhao, Y., Gong, L., Wang, Y., Xu, K., & Gao, Y. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178611 · Cited by 1
Machado, A. L., Pinto, A., Carvalho, J., Fernandes, V., Pereira, L., Roelands, J. P., Gonçalves, J., de Miranda, N. F. C. C., Oliveira, M. J., & Velho, S. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01171-z · Cited by 1
Takeuchi, Y., Terakura, S., Ishigiwa, K., Julamanee, J., Hirano, S., Yokota, H., Kuwano, S., Hanajiri, R., & Kiyoi, H. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012309 · Cited by 1
Zheng, R., Wang, S., Li, D., Tian, X., Sun, L., Wang, J., Wang, Y., Pan, X., Liang, Y., & Yang, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116744 · Cited by 1
Engineering T cell metabolism to enhance therapeutic efficacy
Anderson, L., Mason, N. J., & O’Connor, R. S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.05.001 · Cited by 1
Wei, X., Jiang, Y., Li, Z., Hu, J., Chenwu, F., Li, F., Song, M., He, Y., & Wang, J. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218178 · Cited by 1
Targeting DGAT1 reprograms lipid landscape and restores CD8⁺ T cell immunity in pancreatic cancer
Liu, Z., Chen, L., Zhang, T., Wang, Y., Ma, P., Zhang, X., Liu, R., Zhang, R., Zhang, X., Su, Q., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74315-2 · Cited by 1
Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma
Pucci, M., Costanzo, E., Marfia, M., Seidita, G., Fontana, S., Corrado, C., & Alessandro, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146276 · Cited by 1
β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma
Jiang, N., Wu, T., Yang, R., He, G., Ding, B., Zhu, C., Liu, H., Xu, X., Yang, B., Xie, H., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015401 · Cited by 1
Decoding the Interplay: Exploring Immunotherapy Resistance in the Tumor Microenvironment
Kannabran, S., Ajan, A., Lui, L., & Yet, Z. (2024) · Berkeley Pharma Tech Journal of Medicine · doi:10.52243/bptjm.v4i1.64 · Cited by 1
Diet-responsive proteogenomic effects following short-term restriction of animal products in humans
Simistiras, A., Bocher, O., Emmanouil, C., Skoulakis, A., Glentis, S., Scarmeas, N., Zeggini, E., Rouskas, K., & Dimas, A. S. (2026) · Nature Communications · doi:10.1038/s41467-026-76379-6 · Cited by 1
The role of lipid metabolic interactions in reshaping the tumor microenvironment
Yang, R., Liu, S., Bi, Y., Jin, R., Ye, Z., Cai, X., Bode, A. M., Liu, W., & Luo, X. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025166 · Cited by 1
Varmazyari, S., Borhani, H., Moradipour, Z., Ziaei, H., & Rezaei, N. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03176-1_18 · Cited by 1
Burns, E. A., Giese, N., Mathur, S., Khosla, M., Adroja, S., Hassanain, H. S., Rios, J., Umoru, G., Shah, S. S., Mai, H., et al. (2025) · Blood Immunology & Cellular Therapy · doi:10.1016/j.bict.2025.100021 · Cited by 1
DeConne, T. M., Sitlani, C. M., Delaney, J. A., Psaty, B. M., Doyle, M. F., Otvos, J. D., Feinstein, M. J., & Olson, N. C. (2026) · Global Heart · doi:10.5334/gh.1521 · Cited by 1
Zhang, Y., Xiong, W., Qian, J., Duan, R. X., Guo, Q., Wang, Q., Wu, W., Zhang, C., Li, Y., Xian, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69621-8 · Cited by 1
Self-citationZhang, Q., Meng, L., Wang, Z., Fu, Y., Li, L., Zhang, X., Zhang, H., & Zhang, L. (2026) · Small · doi:10.1002/smll.202514467 · Cited by 1
Saraç, H., Nicholson, R., Graham, R. N., Augustus, M., Taghavi, R., Connolly, D. J., Lim, L., & Lourenco, S. D. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1509926 · Cited by 1
The controversial role of metabolic reprogramming in anti-tumor therapy resistance
Xu, Y., Wang, Y., Fu, Q., Yao, Y., & Zhou, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-04787-7 · Cited by 1
Ma, Q., Chen, B., Li, T., Lu, Y., & Li, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02631-8 · Cited by 1
Self-citationZheng, Y., Zhai, M., Bai, X., Yu, K., Li, J., & Zhang, Z. (2026) · Stem Cells International · doi:10.1155/sci/2846096 · Cited by 1
Talpacci, E., Macera, M., Maida, G., Morelli, S., Leone, V. G., Ingriccini, C., Ferrieri, A., Tortoriello, R., Paci, M., Baldoni, M., et al. (2026) · European Thyroid Journal · doi:10.1530/etj-25-0301 · Cited by 1
T cell exhaustion: next-generation target of autoimmune diseases?
Ouyang, Y., Luo, M., Li, K., Chen, K., Wen, Z., Zhou, Q., Shi, G., Xu, S., Luo, Z., & Yang, H. U. I. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag052 · Cited by 1
Mondal, P., & Bhattacharyya, S. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70215 · Cited by 1
Mast cell driven immunometabolism as a therapeutic entry point in ESCC
Qu, Z., Zheng, X., Zhao, A., Wang, P., Gao, S., & Yin, Q. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1830394 · Cited by 1
Álvarez-Álvarez, A., Fernández, M. G., & Ortiz-Muñoz, G. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.05.001 · Cited by 2
Choudhury, P. R., Chakravarti, M., Bera, S., Arora, P., Sultana, J., Khan, M. A., Biradar, R., Guha, A., Dhar, S., Ghosh, I., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201250 · Cited by 1
Niu, S., Liu, C., & Deng, Q. (2026) · Cell Transplantation · doi:10.1177/09636897261449351 · Cited by 1
Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic Strategies
Yi, Y., Liu, X., Zhang, X., Li, Y., & Zhao, H. (2026) · MedComm – Oncology · doi:10.1002/mog2.70081 · Cited by 1
Liu, Y., Du, W., & Deng, W. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2687543 · Cited by 1
The impact of T cell exhaustion in hematopoietic stem cell transplantation
Li, Y., Guo, H., Zhang, Y., Chen, J., Zhong, L., Huang, X., & Li, Y. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05141-y · Cited by 1
Yu, Z., Qing, H., Wang, T., Xing, Z., Hou, Y., Ma, Y., Wang, T., Chen, S., Shi, W., Qin, L., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338277 · Cited by 1
Zhang, H., Lu, Y., Xiong, H., Shi, L., Xu, H., Jia, Y., Zhao, J., & Sheng, H. (2026) · Nature Communications · doi:10.1038/s41467-026-75415-9 · Cited by 1
Self-citationKim, S. A., Nam, G., Bae, Y. R., Jha, S. K., Kim, S., Choi, Y., Lee, Y., Kwon, M., Jeong, C., Byun, Y., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100025 · Cited by 1
[Cholesterol Metabolism and Tumor Immunity].
Luo, N., Shi, R., Dai, R., & Miao, H. (2022) · PubMed Central · doi:10.12182/20220360202 · Cited by 1
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy
Xing, Z., Jiang, X., Wu, Y., & Yu, Z. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096273730231206054104 · Cited by 1
Dietary alterations to induce antitumor immunity
Saha, S., & Montrose, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00028-x · Cited by 1
Liu, W., Yu, H., Yan, G., Shen, S., Gao, M., & Zhang, X. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04179 · Cited by 1
Sun, J., An, Y., Xu, M., Ma, S.-Y., Liu, C., Xu, J., Xia, Q., & Wang, S. (2024) · Discover Oncology · doi:10.1007/s12672-024-01658-x · Cited by 1
Ali, E. T. O., Mohamed, N. S., Siddig, E. E., & Masri, M. (2025) · BMC Cancer · doi:10.1186/s12885-025-14633-8 · Cited by 1
Effects of low-density lipoprotein cholesterol on lymph node metastasis after radical esophagectomy
Xu, X., Liu, S., Li, J., He, M., Wang, H., & Meng, Q. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i8.106898 · Cited by 1
Shawcross, D. L., & Suddle, A. R. (2021) · Liver Transplantation · doi:10.1002/lt.26381 · Cited by 1
Dai, W., Chen, Y., Gong, W., Su, Y., & Zhang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1797700/v1 · Cited by 1
Martinez-Paniagua, M. A., Haymaker, C., Robinson, J. L., Harel, M., Creasy, C. A., Adolacion, J. R. T., An, X., Fathi, M., Rezvan, A., Kumar, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.28.509590 · Cited by 1
Single-cell and spatial atlas of steatotic liver disease-related hepatocellular carcinomaPreprint
Prawira, A., Xu, H., Leow, W. Q., Otsuka, M., Chen, Z., Rahbari, M., Hazirah, S. N., Wasser, M., Chung, A. Y. F., Goh, B. K. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.09.593073 · Cited by 1
Cysteine reactivity profiling links metabolic rewiring to the dysfunctional human T cell proteomePreprint
Kojima, H., Wayne, C. R., Patterson, L. F. S., Sanford, H., Chen, T.-J., Lin, Y.-H., Schoenfeld, J. D., McGary, L. H. F., Chen, Y., Kropp, K. N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709614 · Cited by 1
Quenum, A., Cloutier, M., Santharam, M. A., Mayhue, M., Ramanathan, S., & Ilangumaran, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.11.246553
Immune Cell Metabolism and Function
Dixit, A. K., & Singh, M. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_1
The role of fatty acids metabolism on cancer progression and therapeutics development
Moreira-Barbosa, C., Matos, A., Fernandes, R., Mendes-Ferreira, M., Rodrigues, R. C., Cruz, T., Costa, Â. M., Cardoso, A. P., Ghilardi, C., Oliveira, M. J., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00007-5
Estudo do papel de receptores LXR na diferenciação de linfócitos TCD4+ in-vitro e in-vivo
Pinto, J. E. L. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2023.tde-03102023-165055
Adaptive IRE1 Signaling Elicits T Cell Metabolic Remodeling and Tumor ControlPreprint
Riesenberg, B., Gandy, E. J., Kennedy, A. S., Hunt, E. G., Hurst, K. E., Sedlacek, E. L., Gao, P., Emanuele, M. J., Modliszewski, J., Green, J. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567431
The extracellular matrix in peritoneal metastatic carcinoma
Qiu, Y. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/15/20240464
Cholesterol Metabolism-Mediated Immune Regulation and Cancer ImmunotherapyPreprint
Zhang, J., Zhu, X., Han, L., Zhang, Z., Huang, X., Zhang, J., Li, J., Guo, C., & Yang, Q. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4760648
Cai, Y., Cheng, Y., Wang, Z., Li, L., Qian, Z., Xia, W., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.23896183
Wang, Z., Wang, M., Zhang, M., Xu, K., Zhang, X., Xie, Y., Zhang, Y., Chang, C., Li, X., Sun, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20454541
Wang, Z., Wang, M., Zhang, M., Xu, K., Zhang, X., Xie, Y., Zhang, Y., Chang, C., Li, X., Sun, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20454553
Wang, Z., Wang, M., Zhang, M., Xu, K., Zhang, X., Xie, Y., Zhang, Y., Chang, C., Li, X., Sun, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20454547
Wang, Z., Wang, M., Zhang, M., Xu, K., Zhang, X., Xie, Y., Zhang, Y., Chang, C., Li, X., Sun, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20454550
Li, H., Sun, X., Zhao, Y., Zhang, C., Jiang, K., Ren, J., Xing, L., & He, M. (2023) · Figshare · doi:10.6084/m9.figshare.23489014
Research Progress of Cholesterol in Tumor and Immune Cells
潘, 吕. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451499
Hu, J., Yang, C., Pan, L.-X., Li, Z., Wang, X., Tao, Y., Wang, Y., Hu, X.-Y., Zhao, J.-F., Wang, Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4479454/v1
Self-citationUnderstand the Fatty Acid Metabolic Reprogramming of Immune Cells in Colorectal Cancer
(2024) · Texila international journal of public health · doi:10.21522/tijph.2013.12.03.art017
Targeting immunometabolism to improve cancer therapies
Ballard, D. J., Wang, L., Das, J. K., Kumar, A., Ren, Y., & Song, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00018-4
Modulating T cell metabolism to improve T cell therapy
Li, Y., Hung, S.-H., Singh, S., & Yee, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00008-1
T cell metabolism and cancer immunotherapy
Li, Q., & Zhang, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00006-8
The Immunometabolism of Natural Killer Cell Responses
Keane, C., Gardiner, C. M., & Finlay, D. K. (2025) · Springer eBooks · doi:10.1007/978-3-662-68816-8_41-1
Yang, J., Xing, Y., Luan, J., Yang, W., Zhang, X., Tian, Y., & Zhang, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-01890-z
Sheng, X., Li, X., Zhang, Q., Ji, Q., & Wang, X. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107137
Tao, L., Xu, B., Sun, J., Yang, J., Meng, F., & Zhong, Z. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01886-w
CAR T cells and metabolic programming: A review
Hatami, S., Kazemi, F., Doroudgar, P., Shushtari, S. S., & Atashzar, M. R. (2025) · Medical Immunology (Russia) · doi:10.15789/1563-0625-ctc-3155
Hypothesis and Evidence: Immune CellTherapy Might Yield Poor Outcomes in Patients with Diabetes
Wang, E., Zhang, B., Hou, H., Tang, J., & Lang, Y. (2025) · Advances in Life Science for Adolescents · doi:10.64135/advadolesc.2025.01.05
Shi, H., Li, T., & Xu, Y. L. N. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2548488
Immunometabolism Governs T Cell Immunity
Raynor, J. L., Shi, H., & Chi, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00275-1
Huang, J., Zhong, C. C., Li, Z., Jiang, Y., Yang, Z., Yuan, J., Poon, J. K., Dou, Q., & Wong, M. C. S. (2025) · Oncology · doi:10.1159/000548220
Mu, Z., Fu, H., Guo, S., Zhang, Z., Wang, Z., Wang, H., & Yin, J. (2025) · Medicine · doi:10.1097/md.0000000000044562
Justice, J. B., Burnette, H., Irlmeier, R. T., Ye, F., & Johnson, D. B. (2025) · Cancers · doi:10.3390/cancers17193230
Camara-Peña, S., Rodríguez-Márquez, P., Planell, N., Calleja-Cervantes, M. E., Jordana-Urriza, L., Cinnirella, G., Reich-Zeliger, S., Rodríguez‐Otero, P., Tamariz‐Amador, L., Ochoa, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.11.681788
Effect of adipocytes on the function and activity of T cells in tumor microenvironment
Zhu, L., Xu, S., Ye, Y., Xiong, Y., & Li, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1688342
Xia, M., Jiang, Y., Li, J., Zhang, Y., Ren, L., Lin, J., Wang, X., & Man, C. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110778
Zhu, S., Chen, Y., & Chen, S. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3123-9
Loschinski, R., Karl, F., Drettwan, D., Wittmann, J., Jacobs, B., Völkl, S., Bruns, H., Mackensen, A., & Mougiakakos, D. (2025) · Clinical & Translational Immunology · doi:10.1002/cti2.70060
Metadata
- Authors
- Ma, X., Bi, E., Lu, Y., Su, P., Huang, C., Liu, L., Wang, Q., Yang, M., Kalady, M. F., Qian, J., Zhang, A., Gupte, A. A., Hamilton, D. J., Zheng, C., & Yi, Q.
- Affiliations
- Houston Methodist (US)
- Wake Forest University Health Sciences (US)
- Cleveland Clinic (US)
- Houston Methodist Research Institute (US)
- Second Hospital of Shandong University (CN)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 30
- Issue
- 1
- Pages
- 143-156.e5
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC7061417
- OpenAlex
- W2941036215
- Cited by
- 1,033
- References
- 45
- Citations by year
- 2026: 176 · 2025: 204 · 2024: 187 · 2023: 169 · 2022: 136 · 2021: 100 · 2020: 47 · 2019: 12
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- cholesterol, CD8+ T cell exhaustion, tumor microenvironment, immune checkpoint, PD-1, 2B4, TIM-3, LAG-3, endoplasmic reticulum stress, XBP1, adoptive T cell therapy, antitumor immunity, cholesterol metabolism
- MeSH terms
- Animals, Cholesterol, Flow Cytometry, Humans, Immunotherapy, Melanoma, Experimental, Blotting, Western, CD8-Positive T-Lymphocytes, Immunoprecipitation, Mice, Tumor Microenvironment, Real-Time Polymerase Chain Reaction, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review